Acute kidney injury diagnostic gets marketing nod from FDA
A first-of-its-kind laboratory test to gauge severe acute kidney injury has been approved for marketing by the Food and Drug Administration. Developed by San Diego’s Astute Medical, the NephroCheck test is meant to be used in critically ill, hospitalized patients. It can gauge whether a patient pool that generally consists of diabetics, the elderly and those […]